Abstract. NUMEROUS STUDIES in recent years have suggested that arginine vasopressin (AVP) may be involved in the development and/or maintenance of experimental hypertension such as that in spontaneously hypertensive rats [1, 2] , and rats made hypertensive by the administration of deoxycorticosterone acetate and salt [3] or by renovascular clipping [4] . However, many investigators have argued against a role of AVP in the maintenance of high blood pressure in spontaneously hypertensive rats [5] , experimental animals with renovascular hypertension [6] or salt--sensitive Dahl rats [7] . Circulating AVP could raise arterial blood pressure by acting on V1-type receptors in vascular vessels, causing vasoconstriction, and/or on V2-type receptors in the renal collecting tubules, causing water retention. However, AVP has been shown to inhibit sympathetic nervous system activity and enhance baroreflex-mediated sympathoinhibition [8, 9] . Furthermore, depressor actions of AVP mediated through V2-type receptors [10] increase in plasma AVP levels with water and sodium retention, as well as a 1.8-fold increase in PGE2 excretion. However, arterial blood pressure was not increased significantly. It is generally known that AVP plays an important role in the maintenance of arterial blood pressure under conditions such as hemorrhage and water deprivation. However, its precise role in the chronic regulation of arterial blood pressure and in the pathogenesis of hypertension is much more controversial. In the present study , AVP-infused animals did show a blunted vasopressor response to a bolus injection of 200 ng of AVP, but not to angiotensin II injection. Since V1-antagonist completely abolished the pressor response to a bolus injection of AVP, these results indicate that V1-type receptor-mediated vasoconstriction may be attenuated after one-week AVP infusion. This might be due to prior occupancy of circulating AVP on vascular V 1-receptors or down-regulation of V 1-receptors in vascular walls. However, the former possibility seems unlikely, because plasma AVP levels achieved by continuous infusion were far lower than the dissociation constant (2 nM) for in vitro binding of AVP to its receptors [ 15] . The renal V2-receptor has been reported to undergo down-regulation in response to acute increases in AVP [ 16] , but little is known about modulation of the vascular V1 receptor by AVP. In AVP-deficient diabetes insipidus rats, the V1 binding site concentration in the liver has been shown to be greater than in Long-Evans control rats, whereas the V2 binding site concentration has been shown to be similar in both strains [ 17] . Enhanced response of isolated mesenteric arteries to AVP, but not to norepinephrine or angiotensin II, has been reported in dexamethasone-induced hypertension [18] , indicating increased sensitivity or number of V1-receptors.
One further point to be noted is baroreceptormediate blood pressure regulation. When changes in heart rate were analyzed in relation to blood pressure changes, the reduction in the heart rate relative to the increase in systolic blood pressure was not significantly attenuated in the group given AVP infusion, implying that the baroreflex was not depressed by continuous AVP infusion in the present study. This is consistent with the results of a previous study demonstrating that the baroreflex was sensitized through V2 receptors accessible from the blood [19] . Taken together, circulating AVP within a physiological range may regulate blood pressure mainly through vascular V1 receptors, possibly through down-regulation of V1 receptors.
It has been reported that AVP stimulates renal PGE2 biosynthesis by enhancing the conversion of phospholipids to arachidonic acid [20] . On the other hand, urinary PGE2 excretion rates have been reported to be dependent on the urine flow rate [21] . Increased urinary PGE2 excretion in AVP-infused rabbits in spite of antidiuresis observed in the present study suggests a stimulatory effect of AVP on renal PGE2. PGE1 has been reported to inhibit AVP-but not cAMP-induced water movement in the toad bladder and isolated collecting duct cells [22, 23] 
